CHB patients with rtA181T‐mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes

Targeted and Persistent 8-Oxoguanine Base Damage at Telomeres Promotes Telomere Loss and Crisis

(2019) Elise Fouquerel et al.   MOLECULAR CELL

An R-loop-initiated CSB–RAD52–POLD3 pathway suppresses ROS-induced telomeric DNA breaks

(2019) Jun Tan et al.   NUCLEIC ACIDS RESEARCH

Hepatitis B virus rtA181T/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T/sW172* mutation

(2018) Li Zhao et al.   ANTIVIRAL RESEARCH

Trends in Hepatitis B Virus Resistance to Nucleoside/Nucleotide Analogs in North China from 2009 to 2016: A Retrospective Study

(2018) Xianghua Guo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Concept of DNA Lesion Longevity and Chromosomal Translocations

(2018) Nicholas R. Pannunzio et al.   TRENDS IN BIOCHEMICAL SCIENCES

HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3

(2016) K Yuan et al.   CELL DEATH AND DIFFERENTIATION

Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis

(2016) Alexander V. Ivanov et al.   Oncotarget

Hepatocarcinogenesis in transgenic mice carrying hepatitis B virus pre-S/S gene with the sW172* mutation

(2016) M-W Lai et al.   Oncogenesis

Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis

(2015) Anna S.F. Lok et al.   HEPATOLOGY

Management of Chronic Hepatitis B: An Overview of Practice Guidelines for Primary Care Providers

(2015) S.-H. Han et al.   Journal of the American Board of Family Medicine

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

(2015) Kornelius Schulze et al.   NATURE GENETICS

EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

(2015)   JOURNAL OF HEPATOLOGY

Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine

(2014) Young–Suk Lim et al.   GASTROENTEROLOGY

Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study

(2014) Chun-Ying Wu et al.   GASTROENTEROLOGY

The Impact of the Hepatitis B Virus Polymerase rtA181T Mutation on Replication and Drug Resistance Is Potentially Affected by Overlapping Changes in Surface Gene

(2014) S. H. Ahn et al.   JOURNAL OF VIROLOGY

Hepatitis B virus infection

(2014) Christian Trépo et al.   LANCET

Current developments in nucleoside/nucleotide analogues for hepatitis B

(2014) Angeline Oi-Shan Lo et al.   Expert Review of Gastroenterology & Hepatology

The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma

(2014) Pengyuan Yang et al.   National Science Review

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients With liver cirrhosis

(2013) Grace Lai-Hung Wong et al.   HEPATOLOGY

Update on epidemiology of hepatitis B and C in China

(2013) Yan Cui et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype

(2012) Wenpeng Li et al.   Hepatology International

First-line treatment of chronic hepatitis B with entecavir or tenofovir in ‘real-life’ settings: from clinical trials to clinical practice

(2012) S. Pol et al.   JOURNAL OF VIRAL HEPATITIS

Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B

(2011) Chau-Ting Yeh et al.   BMC CANCER

Persistent Expression of Hepatitis C Virus Non-Structural Proteins Leads to Increased Autophagy and Mitochondrial Injury in Human Hepatoma Cells

(2011) Victor C. Chu et al.   PLoS One

The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective

(2010) A. P. Venook et al.   ONCOLOGIST

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

(2008) Nadia Warner et al.   HEPATOLOGY